Laura Alberici, Claudio Ricci, Valentina Vicennati, Isabella Sophia Lucy Windle, Carlo Ingaldi, Marco Fichera, Saverio Selva, Eugenio Cosentino, Antonio De Leo, Caterina Balacchi, Cristina Nanni, Rocco D'Andrea, Riccardo Casadei, Guido Di Dalmazi
{"title":"Redefining Hemodynamic Instability in Pheochromocytoma Surgery through Latent Class Analysis.","authors":"Laura Alberici, Claudio Ricci, Valentina Vicennati, Isabella Sophia Lucy Windle, Carlo Ingaldi, Marco Fichera, Saverio Selva, Eugenio Cosentino, Antonio De Leo, Caterina Balacchi, Cristina Nanni, Rocco D'Andrea, Riccardo Casadei, Guido Di Dalmazi","doi":"10.1093/ejendo/lvaf199","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Hemodynamic instability (HDI) during pheochromocytoma surgical resection remains a major anesthesiologic challenge. The definition of HDI is often arbitrary, limiting comparability and risk stratification. We aimed to develop an objective, data-driven classification of intraoperative HDI.</p><p><strong>Methods: </strong>Hemodynamic variables, including systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), and mean arterial pressure (MAP), were collected at five intraoperative time points. Latent class analysis (LCA) was used to classify patients into two groups: low-risk (l-HDI) and high-risk (h-HDI) HDI classes. We compared four LCA models based on different combinations of variables (SBP+DBP, SBP+DBP+HR, MAP, MAP+HR) to identify the optimal classification of HDI, using AIC and BIC for model selection.</p><p><strong>Results: </strong>Among 92 patients, the LCA model based solely on intraoperative MAP yielded the best classification of HDI (AIC: 3783; BIC: 3824). Two latent classes were identified: high-risk HDI (n = 32, 34.8%) and low-risk HDI (n = 60, 65.2%). MAP values were significantly different between the two groups during anesthesia induction (89 vs. 102 mmHg, p < 0.001), pneumoperitoneum induction (83 vs. 94 mmHg, p = 0.002), gland manipulation (95 vs. 131 mmHg, p < 0.001), and immediately post-adrenal vein ligation (79 vs. 83 mmHg, p = 0.039). Multivariable logistic regression showed that patients' age (OR 1.04 per year; 95% CI 1.01-1.02; p=0.047) and symptomatic presentation (OR 15.35; 95% CI 4.19-56.2; p<0.001) were strongly associated with HDI.</p><p><strong>Conclusion: </strong>This study proposes a reproducible and objective classification of intraoperative HDI in pheochromocytoma surgery based on MAP-derived latent class analysis.</p>","PeriodicalId":11884,"journal":{"name":"European Journal of Endocrinology","volume":" ","pages":""},"PeriodicalIF":5.2000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ejendo/lvaf199","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Hemodynamic instability (HDI) during pheochromocytoma surgical resection remains a major anesthesiologic challenge. The definition of HDI is often arbitrary, limiting comparability and risk stratification. We aimed to develop an objective, data-driven classification of intraoperative HDI.
Methods: Hemodynamic variables, including systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), and mean arterial pressure (MAP), were collected at five intraoperative time points. Latent class analysis (LCA) was used to classify patients into two groups: low-risk (l-HDI) and high-risk (h-HDI) HDI classes. We compared four LCA models based on different combinations of variables (SBP+DBP, SBP+DBP+HR, MAP, MAP+HR) to identify the optimal classification of HDI, using AIC and BIC for model selection.
Results: Among 92 patients, the LCA model based solely on intraoperative MAP yielded the best classification of HDI (AIC: 3783; BIC: 3824). Two latent classes were identified: high-risk HDI (n = 32, 34.8%) and low-risk HDI (n = 60, 65.2%). MAP values were significantly different between the two groups during anesthesia induction (89 vs. 102 mmHg, p < 0.001), pneumoperitoneum induction (83 vs. 94 mmHg, p = 0.002), gland manipulation (95 vs. 131 mmHg, p < 0.001), and immediately post-adrenal vein ligation (79 vs. 83 mmHg, p = 0.039). Multivariable logistic regression showed that patients' age (OR 1.04 per year; 95% CI 1.01-1.02; p=0.047) and symptomatic presentation (OR 15.35; 95% CI 4.19-56.2; p<0.001) were strongly associated with HDI.
Conclusion: This study proposes a reproducible and objective classification of intraoperative HDI in pheochromocytoma surgery based on MAP-derived latent class analysis.
目的:嗜铬细胞瘤手术切除期间的血流动力学不稳定(HDI)仍然是一个主要的麻醉学挑战。人类发展指数的定义往往是武断的,限制了可比性和风险分层。我们的目的是建立一个客观的、数据驱动的术中HDI分类。方法:收集术中5个时间点的血流动力学指标,包括收缩压(SBP)、舒张压(DBP)、心率(HR)和平均动脉压(MAP)。使用潜类分析(LCA)将患者分为两组:低危(l-HDI)和高危(h-HDI) HDI组。我们比较了4种基于不同变量组合(收缩压+舒张压、收缩压+舒张压+HR、MAP、MAP+HR)的LCA模型,以确定HDI的最佳分类,并使用AIC和BIC进行模型选择。结果:92例患者中,单纯基于术中MAP的LCA模型HDI分类最佳(AIC: 3783; BIC: 3824)。确定了两种潜在类别:高危HDI (n = 32, 34.8%)和低危HDI (n = 60, 65.2%)。两组在麻醉诱导(89 vs 102 mmHg, p < 0.001)、气腹诱导(83 vs 94 mmHg, p = 0.002)、gland操作(95 vs 131 mmHg, p < 0.001)和肾上腺静脉结扎后立即(79 vs 83 mmHg, p = 0.039)时MAP值有显著差异。多变量logistic回归显示患者年龄(OR 1.04 /年;95% CI 1.01-1.02; p=0.047)和症状表现(OR 15.35; 95% CI 4.19-56.2; p结论:本研究基于map衍生的潜在分类分析,提出了嗜铬细胞瘤手术中HDI的可重复性和客观分类。
期刊介绍:
European Journal of Endocrinology is the official journal of the European Society of Endocrinology. Its predecessor journal is Acta Endocrinologica.
The journal publishes high-quality original clinical and translational research papers and reviews in paediatric and adult endocrinology, as well as clinical practice guidelines, position statements and debates. Case reports will only be considered if they represent exceptional insights or advances in clinical endocrinology.
Topics covered include, but are not limited to, Adrenal and Steroid, Bone and Mineral Metabolism, Hormones and Cancer, Pituitary and Hypothalamus, Thyroid and Reproduction. In the field of Diabetes, Obesity and Metabolism we welcome manuscripts addressing endocrine mechanisms of disease and its complications, management of obesity/diabetes in the context of other endocrine conditions, or aspects of complex disease management. Reports may encompass natural history studies, mechanistic studies, or clinical trials.
Equal consideration is given to all manuscripts in English from any country.